Gene Mack, CEO, GAIN Therapeutics, highlights early Phase Ib data showing GT-02287 may enhance neuroprotection across a wider spectrum of Parkinson’s patients regardless of genetic status.

Get key insights into Talkspace's Q2 2025 earnings, with 18% revenue growth, AI innovation, payer momentum, and expanding partnerships driving ...

Q2 2025 Management View CEO Christopher C. Gibson emphasized the integration of Exscientia's technology into Recursion OS ...

Q2 2025 Management View CEO R. Jeffrey Bailly highlighted a strong second quarter, reporting "revenue grew 37% with 5% organic growth. Adjusted operating income increased 35%, and adjusted EPS grew 27 ...

Furthermore, the Company has been provided an update that its first orders of twenty (20) ElphaPex DG1+ miners are scheduled ...

Broadridge Financial Solutions (BR) shares gapped up 6.9% in Tuesday afternoon trading after initiating a stronger-than-expected growth outlook for fiscal-year 2026 on the heels of a double-beat on ...

Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) could see a strong end to the year, according to fresh technical analysis by ...

Analysts expect the San Jose, California-based company to report quarterly earnings at 44 cents per share, down from 62 cents ...

How leading retailers use search intelligence to navigate AI overviews, optimize shopping ads, and win market share.

ADM topped Q2 EPS expectations despite softer sales and segment profits, narrowed full-year guidance, and sees biofuel policy ...

Backlog -- Backlog reached a record of nearly $23 billion in Q3 fiscal 2025, up 14% year-over-year; Trailing twelve-month ...

ATB Capital Markets analyst Martin Toner reiterated his “Sector Perform” rating and raised his price target to $18.00 from ...